George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Ok, you win the most depressing post of the day.
@Daniel - Maybe those selfish people go to work, because they have to.
If you dont work, you dont get paid.
This situation will force their hand.
GLR1990 - very good point. People need to change the way they deal with coughs, colds, flus etc. There are millions of people with underlying conditions that are extremely susceptible to secondary, more serious problems when faced with virus attacks. Do these selfish people who go to work with coughs/colds etc think they are martyrs or something ? Covid-19 will remain a serious and deadly threat to the world and the test Avacta are developing is vital IMO. More serious and deadly pathogens will occur in the future and destroy the world's economies, as this one has done, so the governments should not become ignorant of these threats. As a shielded individual, nothing has changed for me, the virus is out there and it will most likely finish me. Only when there is mass testing, drug treatment and finally a vaccine will it be safe again. GLA
Sorry PL75 didn't mean that post to come across as a disagreement to your statement, was unsure if you understood that little to no cases = huge demand for mass screening, which you clearly do - so I will end with, agreed!!! :-)
GLR, we're violently agreeing, I think Awacta's test for mass screening is needed at all levels of infection
In theory these test could be used for any type of virus testing, and Medusa19 website seems to allude to this.
Think about the endless possibilities of cheap highly accurate rapid testing for...any virus.
C3, I could kiss you for your continuous plugging of Have I Got Flus For You
PL75 the logic is around MASS testing, AKA screening the entire population
Argument against AVCT - numbers are decreasing so we no longer need as many tests
Argument for AVCT - in the case of Wuhan, experts argued the best time to mass test a population was when infections are very low prevalence, so you can be sure that by the time the testing is done, the cases have not risen elsewhere/spread of infection messes with your data
I am saying, that in terms of testing, this is still very much the beginning, and the major orders (10-50m+) are coming - with evidence and reason to support that logic
https://tinyurl.com/yb8l2xwm
WHO - 1 Billion cases of flu per year!! So, if you need to test when you get flu like symptoms that's 1 Billion tests required...in addition to the legitimate CV19 cases!
Hmm interesting, never really thought of it that way
If I get a cold/flu in the winter, id certainly be ordering one of these test kits, although really nobody should go out with the flu anyway, not like its acceptable to give it to somebody else :-)
I wonder if our mentality will change to other viruses, I know a lot of people go to work with the cold, the flu (they have to for money) I've been served by many people with flu like symptoms in the past and always been a little cautious but mostly just 'got on with it' - that certainly wont ever be happening again!
Most interesting
Did someone just mention Have I Got Flus For You?
Meanwhile, I still don't follow the logic :-) Awacta's test will be needed at ALL levels of infection
Just to add to that, as I've said before I see a massive spike in demand for testing when seasonal flu and the common cold season kicks off in the Autumn. The government advice will not have changed, if you have flu like symptoms self isolate until tested negative......just think about it...that is millions and millions of people!!!
Re-post as is now on Page 3 and just making sure nobody has missed the absolute game changer of this quote
But with confirmed, symptomatic infections remaining in the single digits in Wuhan, some experts said the scale of Wuhan’s campaign was excessive. Jin Dongyan, a virologist at the University of Hong Kong, said it would be impossible to accurately test that many people in such a short period
Just one more time 'Jin Dongyan, a virologist at the University of Hong Kong, said it would be impossible to accurately test that many people in such a short period'
Step in AVCT
Bow String 1
https://twitter.com/glr_1990/status/1268090871179874304
I decided to try and summarise some recent research with a quick and easy digestion around the Cytiva/AVCT collaboration - I used the recent example in Wuhan to show why AVCT could easily receive orders in the 10's of millions from individual governments
I did also come across something interesting, its on the tweet above - to quote "it works only in places where there is a low prevalence of infections'
This is super interesting because as everyone see's the current rate of infection drop, investors quickly think that the pandemic is over and there is no need for testing, however it is at THAT point that we actually require mass testing, because mass testing can be used to screen the population when the rate of infection is very low to conclude that it either no longer exists, find every remaining asymptomatic case, and finally wipe it out - this could be done say once a week, or a month, to ensure that until we find a vaccine or cure, the virus is pretty much extinct (or controlled)
This new piece of info has really changed my view on the POC home based testing market, no wonder they state demand could be for years, because this actually proves why - if there are only a few infections, that's the best time to mass screen the population, not when there are loads, because your data will change very quickly
In light of this, I am now more relaxed with AVCT bringing the test out mid summer, versus rushing it out and getting it wrong or having to go back and do more work - the sooner the better of course as this will save lives, but in terms of mass screening populations, that will come when cases are very low IMO
GLA
I'm not sure I follow the logic, Avacta's test will be needed at all levels of infection. Given the r value of 3, even if there's a single human that has it and is infectious you will want to find out who it is, as well as now, to isolate the huge numbers that are contagious. There'll be unbelievably huge initial demand for mass screening as govts want to firmly get on top of the outbreak, following that, it'll be about keeping infection levels low to start allowing mass gatherings. Then you'll want testing to be confident of the use of public transport, flights etc.
But yes, we're in the strange position of having a product where the more successful it is, the quicker its widespread use will decline. However, by then the whole world will know about the benefits of affimers and the true value will out. Not a bad position to be in.
Bow String 1
https://twitter.com/glr_1990/status/1268090871179874304
I decided to try and summarise some recent research with a quick and easy digestion around the Cytiva/AVCT collaboration - I used the recent example in Wuhan to show why AVCT could easily receive orders in the 10's of millions from individual governments
I did also come across something interesting, its on the tweet above - to quote "it works only in places where there is a low prevalence of infections'
This is super interesting because as everyone see's the current rate of infection drop, investors quickly think that the pandemic is over and there is no need for testing, however it is at THAT point that we actually require mass testing, because mass testing can be used to screen the population when the rate of infection is very low to conclude that it either no longer exists, find every remaining asymptomatic case, and finally wipe it out - this could be done say once a week, or a month, to ensure that until we find a vaccine or cure, the virus is pretty much extinct (or controlled)
This new piece of info has really changed my view on the POC home based testing market, no wonder they state demand could be for years, because this actually proves why - if there are only a few infections, that's the best time to mass screen the population, not when there are loads, because your data will change very quickly
In light of this, I am now more relaxed with AVCT bringing the test out mid summer, versus rushing it out and getting it wrong or having to go back and do more work - the sooner the better of course as this will save lives, but in terms of mass screening populations, that will come when cases are very low IMO
GLA